Patient factors, endotypic traits predict tirzepatide impact in patients with OSA, obesity

ORLANDO — Patients with obstructive sleep apnea and obesity who had strong- vs. moderate-response endotype characteristics had more improvement in obstructive sleep apnea severity with tirzepatide, according to data presented here.These findings were presented at the American Thoracic Society International Conference.